These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 9390333

  • 21. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
    Seidenari S, Di Nardo A, Mantovani L, Giannetti A.
    Exp Dermatol; 1997 Apr; 6(2):75-80. PubMed ID: 9209888
    [Abstract] [Full Text] [Related]

  • 22. Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity.
    Geba GP, Ptak W, Askenase PW.
    Immunology; 2001 Oct; 104(2):235-42. PubMed ID: 11683964
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. What's new in the topical treatment of allergic skin diseases.
    Aslam I, Sandoval LF, Feldman SR.
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):436-50. PubMed ID: 25061854
    [Abstract] [Full Text] [Related]

  • 25. Macrolide immunosuppressants.
    Mrowietz U.
    Eur J Dermatol; 1999 Oct; 9(5):346-51. PubMed ID: 10417434
    [Abstract] [Full Text] [Related]

  • 26. Clobetasol propionate--where, when, why?
    Pels R, Sterry W, Lademann J.
    Drugs Today (Barc); 2008 Jul; 44(7):547-57. PubMed ID: 18806904
    [Abstract] [Full Text] [Related]

  • 27. Topical ketoconazole does not potentiate oral cyclosporin A in allergic contact dermatitis.
    McLelland J, Shuster S.
    Acta Derm Venereol; 1992 Aug; 72(4):285. PubMed ID: 1357888
    [Abstract] [Full Text] [Related]

  • 28. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG.
    Int Arch Allergy Immunol; 2006 Aug; 141(3):199-212. PubMed ID: 16926539
    [Abstract] [Full Text] [Related]

  • 29. Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases.
    Lipozencić J.
    Acta Dermatovenerol Croat; 2005 Aug; 13(1):63-9. PubMed ID: 15788149
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Spotlight on topical pimecrolimus in atopic dermatitis.
    Wellington K, Jarvis B.
    Am J Clin Dermatol; 2002 Aug; 3(6):435-8. PubMed ID: 12113651
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y, Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group.
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [Abstract] [Full Text] [Related]

  • 37. Topical application of artesunate on guinea pig allergic contact dermatitis.
    Chen H, Maibach HI.
    Contact Dermatitis; 1994 May; 30(5):280-2. PubMed ID: 8088141
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis.
    Bhol KC, Schechter PJ.
    Br J Dermatol; 2005 Jun; 152(6):1235-42. PubMed ID: 15948987
    [Abstract] [Full Text] [Related]

  • 40. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E, Burgdorf WH, Wollenberg A.
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.